Efficacy of T-HEMOVINE as Topical Hemostatic Agent: A Clinical Study
DOI:
https://doi.org/10.3889/oamjms.2023.11224Keywords:
Topical Hemostatic, , postoperative, , surgisponsAbstract
AIM: Clinical trials using hemostatic T-Hemovine derived from bovine gelatin, to stop bleeding during surgery was performed.
METHODS: Twenty (20) patients (aged 8 months–70 years) who underwent neurosurgery at Dr. Wahidin Sudirohusodo Hospital and Hasanuddin University Teaching Hospital, from September 16, to December 13, 2019, are willing to receive T-Hemovine to control bleeding.
RESULTS: This approach was successfully used in twenty patients. Four patients stopped bleeding at the 3rd min (20%), nineteen patients stopped bleeding at the 5th min or less (95%) and twenty patients stopped bleeding before the 10th min (100%). There were no post-operative bleeding events, no infection, and no other post-operative complications.
CONCLUSION: Therefore, there is no effect, and the safety of using T-Hemovine hemostatic is the same as the effect and safety of using surgeon hemostatic and other hemostatic.
Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Norman G, Shi C, Goh EL, Murphy EM, Reid A, Chiverton L, et al. Negative pressure wound therapy for surgical wounds healing by primary closure. Cochrane Database Syst Rev. 2020;2022(4):CD009261. https://doi.org/10.1002/14651858.CD009261.pub6 PMid:35471497 DOI: https://doi.org/10.1002/14651858.CD009261.pub7
Weaver FA, Hood DB, Zatina M, Messina L, Badduke B. Gelatin- thrombin-based hemostatic sealant for intraoperative bleeding in vascular surgery. Ann Vasc Surg. 2002;16(3):286-93. http://doi.org/10.1007/s10016-001-0073-0 PMid:11957004 DOI: https://doi.org/10.1007/s10016-001-0073-0
Aubourg R, Putzolu J, Bouche S, Galmiche H, Denis C, d’Andon A, et al. Surgical haemostatic agents: Assessment of medical devices and blood derived drugs. J Visc Surg. 2011;148(6):459-62. https://doi.org/10.1016/j.jviscsurg.2011.10.001 PMid:22136914 DOI: https://doi.org/10.1016/j.jviscsurg.2011.10.001
Pereira BM, Bortoto JB, Fraga GP. Topical hemostatic agents in surgery:Review and prospects. Rev Col Bras Cir. 2018;45(5):e1900. http://doi.org/10.1590/0100-6991e-20181900 PMid:30365692 DOI: https://doi.org/10.1590/0100-6991e-20181900
Peng HT. Hemostatic agents for prehospital hemorrhage control: A narrative review. Mil Med Res. 2020;7(1):13. http://doi.org/10.1186/s40779-020-00241-z PMid:32209132 DOI: https://doi.org/10.1186/s40779-020-00241-z
Heller HT, Walker BS, Sadow CA, Frates MC. Imaging appearance of topical haemostatic agents: Pictorial review. Br J Radiol. 2017;90(1070):20160664. http://doi.org/10.1259/bjr.20160664 PMid:27936887 DOI: https://doi.org/10.1259/bjr.20160664
2020. Indonesia Ministry of Health. Protocol of Healthy Mothers and New Baby Born Services during Pandemic COVID-19. Available: https://infeksiemerging.kemkes.go.id/download [Last accessed on 2022 Aug 25].
Indonesia Ministry of Health. The Regulation how to test good medical devices. In: Appendix II Part A: General Principles of the Need for Clinical Trials. Indonesia: Indonesia Ministry of Health; 2017. p. 41.
Arble E, Arnetz BB. Anticoagulants and the hemostatic system: A primer for occupational stress researchers. Int J Environ Res Public Health. 2021;18(20):10626. http://doi.org/10.3390/ijerph182010626 PMid:34682370 DOI: https://doi.org/10.3390/ijerph182010626
De Pablo-Moreno JA, Serrano LJ, Revuelta L, Sánchez MJ, Liras A. The vascular endothelium and coagulation: Homeostasis, disease, and treatment, with a focus on the Von Willebrand factor and factors VIII and V. Int J Mol Sci. 2022;23(15):8283. http://doi.org/10.3390/ijms23158283 PMid:35955419 DOI: https://doi.org/10.3390/ijms23158283
Downloads
Published
How to Cite
License
Copyright (c) 2023 Andi Asadul Islam, Juliani Ibrahim, Venansius R. Kurniawan (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
http://creativecommons.org/licenses/by-nc/4.0
